RESÚMENES ABRIL 2009

.

Other Neuropsychiatric Disorders & General Information

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3! - Previously Undetected Metabolic Syndromes and Infectious Diseases Among Psychiatric Inpatients

Aileen B. Rothbard, Michael B. Blank, Jeffrey P. Staab, Thomas TenHave, Donald S. Young, Sheila D. Berry, and Susan Eachus

Psychiatr Serv 60:534-537, April 2009

3 - Effects of Quetiapine on Sleep in Nonpsychiatric and Psychiatric Conditions

Jessica N Wine, Christina Sanda, Joshua Caballero

The Annals of Pharmacotherapy: Vol. 43, No. 4, pp. 707-713

 

5< - Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial

S. Yancheva;  R. Ihl;  G. Nikolova;  P. Panayotov;  S. Schlaefke;  R. Hoerr; for the GINDON Study Group

Aging & Mental Health, Volume 13, Issue 2 March 2009, pages 183 - 190

 

GRATIS 3 - Delirium in elderly adults: diagnosis, prevention and treatment

Tamara G. Fong, Samir R. Tulebaev & Sharon K. Inouye

Nature Reviews Neurology 5, 210-220 (April 2009)

 

3 - Incidence and outcomes of bulimia nervosa: a nationwide population-based study

A. Keski-Rahkonen, H. W. Hoek, M. S. Linna, A. Raevuori, E. Sihvola, C. M. Bulik, A. Rissanen and J. Kaprio

Psychological Medicine (2009), 39:823-831

 

3! - Resolving the relationship between ApolipoproteinE and depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael A. Slifer, Eden R. Martin, John R. Gilbert, Jonathan L. Haines and Margaret A. Pericak-Vance

Neuroscience Letters. Volume 455, Issue 2, 15 May 2009, Pages 116-119

 

3 - Theta Burst Stimulation of the Prefrontal Cortex: Safety and Impact on Cognition, Mood, and Resting Electroencephalogram




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Nicola Grossheinrich, Anne Rau, Oliver Pogarell, Kristina Hennig-Fast, Maren Reinl, Susanne Karch, Alica Dieler, Gregor Leicht, Christoph Mulert, Andrea Sterr and Frank Padberg

Biological Psychiatry. Volume 65, Issue 9, 1 May 2009, Pages 778-784

3 - Alternative Immunotherapy Approaches for Alzheimer's Disease

Town, Terrence

CNS & Neurological Disorders - Drug Targets, Volume 8, Number 2, April 2009 , pp. 114-127

 

3 - Critical Issues for Successful Immunotherapy in Alzheimer's Disease: Development of Biomarkers and Methods for Early Detection and Intervention

Tarawneh, RawanHoltzman, David M.

CNS & Neurological Disorders - Drug Targets, Volume 8, Number 2, April 2009 , pp. 144-159

 

4 - Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.

Aronson, Stephen; Baelen, Bart Van; Kavanagh, Shane; Schwalen, Susanne

Drugs & Aging. 26(3):231-239, 2009

3 - Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

Raymond A Plodkowski, Quang Nguyen, Umasankari Sundaram, Loida Nguyen, Diane L Chau & Sachiko St Jeor

Expert Opinion on Pharmacotherapy. April 2009, Vol. 10, No. 6, Pages 1069-1081

 

3! - Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus

Rachel A. Whitmer, Andrew J. Karter, Kristine Yaffe, Charles P. Quesenberry Jr, Joseph V. Selby

JAMA. 2009;301(15):1565-1572

 

3! - The prevention of dementia

Ruth Peters

International Journal of Geriatric Psychiatry. Volume 24 Issue 5, Pages 452 - 458

 

3! - Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease

Howard H. Feldman, Tuula Pirttila, Jean François Dartigues, Brian Everitt, Bart Van Baelen, Susanne Schwalen, Shane Kavanagh

International Journal of Geriatric Psychiatry. Volume 24 Issue 5, Pages 479 - 488

 

3! - Use of benzodiazepines, depressive symptoms and cognitive function in old age

Peter van Vliet, Roos C. van der Mast, Marianne van den Broek, Rudi G. J. Westendorp, Anton J.M. de Craen

International Journal of Geriatric Psychiatry. Volume 24 Issue 5, Pages 500 - 508

 

4 - Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies

Patrizia Mecocci, Anna Bladström, Karina Stender

International Journal of Geriatric Psychiatry. Volume 24 Issue 5, Pages 532 - 538

 

3! - Powerful beneficial effects of macrophage colony-stimulating factor on β-amyloid deposition and cognitive impairment in Alzheimer's disease

Vincent Boissonneault, Mohammed Filali, Martine Lessard, Jane Relton, Gordon Wong and Serge Rivest

Brain 2009 132(4):1078-1092

 

5< - Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial

Guerdjikova, Anna I.; McElroy, Susan L.; Welge, Jeffrey A.; Nelson, Erik; Keck, Paul E.; Hudson, James I.

International Clinical Psychopharmacology: May 2009 - Volume 24 - Issue 3 - pp 150-158

 

3 - What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Marianna Mazza, Osvaldo Mazza, Massimiliano Pomponi, Marco Di Nicola, Luca Padua, Massimo Vicini, Pietro Bria and Salvatore Mazza

Comprehensive Psychiatry. Volume 50, Issue 3, May-June 2009, Pages 240-244

 

3 - Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia: A 1-Year, Open-Label Study

Gary S. Richardson, Gary Zammit, Sherry Wang-Weigand, and Jeffrey Zhang

J Clin Psychiatry 2009;70(4):467-476

 

3 - Medically unexplained symptoms, somatisation disorder and hypochondriasis: Course and prognosis. A systematic review




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Tim C. olde Hartman, Machteld S. Borghuis, Peter L.B.J. Lucassen, Floris A. van de Laar, Anne E. Speckens and Chris van Weel

Journal of Psychosomatic Research. Volume 66, Issue 5, May 2009, Pages 363-377

 

3 - The relationship between fatigue and psychiatric disorders: Evidence for the concept of neurasthenia




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Samuel B. Harvey, Simon Wessely, Diana Kuh and Matthew Hotopf

Journal of Psychosomatic Research. Volume 66, Issue 5, May 2009, Pages 445-454

 

5 - Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

Dementias - Original Article

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

Bai-song Wang, Hao Wang, Zhao-hui Wei, Yan-yan Song, Lu Zhang and Hong-zhuan Chen

Journal of Neural Transmission. Volume 116, Number 4 / April, 2009: 457-465

 

3 - A pilot study of impulsivity and compulsivity in pathological gambling

Carlos Blanco, Marc N. Potenza, Suck Won Kim, Angela Ibáñez, Rocco Zaninelli, Jerónimo Saiz-Ruiz and Jon E. Grant

Psychiatry Research. Volume 167, Issues 1-2, 15 May 2009, Pages 161-168  

 

3 - Suicidality in People Taking Antiepileptic Drugs: What is the Evidence?

Bell, Gail S; Mula, Marco; Sander, Josemir W

CNS Drugs. 23(4):281-292, 2009

3! - Benzodiazepine Use and Driving: A Meta-Analysis

Mark J. Rapoport, Krista L. Lanctôt, David L. Streiner, Michel Bédard, Evelyn Vingilis, Brian Murray, Ayal Schaffer, Kenneth I. Shulman, and Nathan Herrmann

J Clin Psychiatry April 21, 2009: e1-e11

 

3 - Challenges in the Search for Drugs to Treat Central Nervous System Disorders

S. J. Enna, and M. Williams

JPET 329:404-411, 2009

 

3! - Association of Antipsychotic Use With Hospital Events and Mortality Among Medicare Beneficiaries Residing in Long-Term Care Facilities

Simoni-Wastila, Linda; Ryder, Priscilla T; Qian, Jingjing; Zuckerman, Ilene H; Shaffer, Thomas; Zhao, Lirong

American Journal of Geriatric Psychiatry: May 2009 - Volume 17 - Issue 5 - pp 417-427

 

3 - A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam

Original Investigation

A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam

Carlo Cifani, Carlo Polidori, Sergio Melotto, Roberto Ciccocioppo and Maurizio Massi

Psychopharmacology. Volume 204, Number 1 / May, 2009: 113-125

 

3 - The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica)




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Marta Grabiec, Kris Turlejski and Rouzanna L. Djavadian

European Neuropsychopharmacology. Volume 19, Issue 6, June 2009, Pages 431-439

 

5 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Patients With Intermittent Explosive Disorder

Emil F. Coccaro, Royce J. Lee, and Richard J. Kavoussi

J Clin Psychiatry April 21, 2009: e1-e10

 

3 - Metabolic links between diabetes and Alzheimer’s disease

Pamela A Maher and David R Schubert

Expert Review of Neurotherapeutics. May 2009, Vol. 9, No. 5, Pages 617-630

 

3 - Secretase inhibitors and modulators for Alzheimer’s disease treatment

Taisuke Tomita

Expert Review of Neurotherapeutics. May 2009, Vol. 9, No. 5, Pages 661-679

 

GRATIS 3 - A Prospective Pilot Study of Levetiracetam for Body Dysmorphic Disorder

Katharine A. Phillips, and William Menard

CNS Spectr. 2009;14(5):252-260

 

3 - Cholinesterase Inhibitors and Beyond
Giancarlo Pepeu and Maria Grazia Giovannini

Current Alzheimer Research. Volume 6, Number 2, April 2009

.

Regresar a RESÚMENES ABRIL 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.